相关实验视频

Updated: Jul 12, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

来自患有LRRK2-和SNCA相关的帕金森病遗传形式的患者的多巴胺能神经元中的线粒体功能障碍

Anna S Vetchinova¹, Marina R Kapkaeva¹, Mikhail V Ivanov²

¹Laboratory of Neurobiology and Tissue Engineering, Brain Science Institute, Research Center of Neurology, Moscow 125367, Russia.

Current issues in molecular biology

|October 27, 2023

概括

在LRRK2和SNCA基因的遗传突变与帕金森病 (PD) 有关. 线粒体基因活动和结构在PD患者衍生细胞中发生变化,为早期诊断提供了潜在的生物标志物.

科学领域:

神经科学是一个神经科学.
遗传学遗传学是一个
细胞生物学细胞生物学

背景情况:

帕金森病 (PD) 是一种流行的神经退行性疾病,具有遗传联系,特别是LRRK2和SNCA基因的突变.
早期诊断PD对于开发有效的神经保护策略至关重要,强调需要可靠的生物标志物.
诱导多能干细胞 (iPSC) 技术为PD建模和在体外发现新生物标志物提供了一个强大的平台.

研究的目的:

调查与LRRK2-和SNCA相关的帕金森病患者的iPSC衍生的多巴胺基神经元中的线粒体基因表达和超结构变化.
为了确定潜在的线粒体生物标志物用于早期诊断和帕金森病的预后.

主要方法:

在纳米链平台上利用多重基因表达概况与条码分析分析了105个线粒体蛋白质组基因.
使用电子显微镜检查患者衍生的iPSC培养中的超结构性线粒体形态.
从PD患者 (LRRK2和SNCA突变) 的iPSC衍生的神经元与健康的捐赠者之间的基因活性和线粒体形态比较.

主要成果:

电子显微镜揭示了与健康对照人群相比,LRRK2和SNCA突变细胞中的超结构性线粒体异常.
在SNCA突变细胞中,线粒体面积与细胞质总面积的比例显著降低.
纳米链分析确定了包括呼吸系统复合体,ATP生产,线粒体-内分泌网膜相互作用,线粒体衰变,调节和线粒体DNA复制在内的途径中的差异性基因表达.

结论:

线粒体功能障碍是帕金森病遗传形式的一个关键特征,在超结构和基因表达水平上都很明显.
在iPSC衍生的神经元中改变了线粒体基因活性,这代表了确定帕金森病的诊断和预后生物标志物的有希望的途径.
这项研究强调了iPSC技术与先进的分析技术相结合的潜力,以了解PD病变发生和生物标志物发现.

关键词:

这是LRRK2 帕金森病是帕金森氏症的一种疾病.这就是SCNA SCNA.这是一种α-synuclein.达尔达林 (Dardarin) 是一种疾病.多巴胺类神经元的神经元诱导多能干细胞的诱导干细胞.线粒体中的线粒体.翻译学翻译学翻译学翻译学

更多相关视频

Author Spotlight: Decoding Mitochondrial Aging

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia

Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia

Published on: February 9, 2020

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.